CD79A and asthma: C. pneumoniae–specific IgA antibodies have been suggested as potential seroepidemiological markers for chronic infection in asthma [7] and might be useful in epidemiological and primary care asthma studies where direct microbiologic sampling of the lower airway is impractical.